Prime Therapeutics unveils its first diversity report
On February 25, 2022, Prime Therapeutics LLC (Prime) released its inaugural diversity, equity and inclusion (DEI) transparency report. The report highlights the goals of Prime's Diversity & Inclusion Council, including adopting a "radical welcome-ness" policy that aims to provide equal employment opportunities for individuals regardless of ethnicity, race, sexual orientation, or background. The report comes as Prime earned a perfect score on Human Rights Campaign Foundation's 2022 Corporate Equality Index.
New Activity|ESGIn response to volatile demand in the wake of the first COVID-19 surge, the company undertook a comprehensive cost reduction program, aimed at shoring up labor and supply costs.
Lorem Ipsum text header Report Title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas non leo lacinia, consectetur ipsum non, pretium augue. Vestibulum accumsan dignissim massa, eu scelerisque mi malesuada ut. Aliquam scelerisque facilisis nisl ac varius. Nunc luctus nunc vel eros iaculis, vitae tristique ante fringilla. Ut vitae vulputate est, vel lacinia nisi. Curabitur eget nulla vitae mi faucibus imperdiet. Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.
Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.
